The anti-obesity and gut microbiota modulating effects of taxifolin in C57BL/6J mice fed with a high-fat diet

© 2021 Society of Chemical Industry..

BACKGROUND: Taxifolin is a natural dihydroflavonol found in many plants and health products. In the present study, its anti-obesity and gut microbiota modulating effects were studied. C57BL/6J mice were fed with a high-fat diet (HFD) supplemented with taxifolin (0, 0.5 and 1 mg mL-1 , respectively) in drinking water for 15 weeks.

RESULTS: Taxifolin supplementation showed no influence on food and water intake. However, it decreased body weight gain, inhibited fat accumulation, and decreased total cholesterol and triacylglycerol level in mice liver. Taxifolin enhanced superoxide dismutase (SOD) activity in mice liver, which in turn protected the liver from lipid peroxidation damage. It also improved insulin resistance in obese mice. Metagenomic analysis of bacterial 16S rRNA demonstrated that HFD decreased gut microbiota diversity and caused dysbiosis. However, taxifolin improved the gut microbiota diversity and decreased the Firmicutes/Bacteroidetes ratio. In particular, it inhibited Proteobacteria from blooming, this being a signature of dysbiosis in gut microbiota.

CONCLUSION: Taxifolin ameliorated the symptoms of obesity, hepatic steatosis, lipid peroxidation, insulin resistance, and gut microbiota dysbiosis in HFD fed C57BL/6J mice. © 2021 Society of Chemical Industry.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:102

Enthalten in:

Journal of the science of food and agriculture - 102(2022), 4 vom: 15. März, Seite 1598-1608

Sprache:

Englisch

Beteiligte Personen:

Su, Hang [VerfasserIn]
Wang, Wen-Jun [VerfasserIn]
Zheng, Guo-Dong [VerfasserIn]
Yin, Zhong-Ping [VerfasserIn]
Li, Jing-En [VerfasserIn]
Chen, Ling-Li [VerfasserIn]
Zhang, Qing-Feng [VerfasserIn]

Links:

Volltext

Themen:

9IKM0I5T1E
9SOB9E3987
Gut microbiota
Insulin resistance
Journal Article
Obesity
Quercetin
RNA, Ribosomal, 16S
Taxifolin

Anmerkungen:

Date Completed 14.02.2022

Date Revised 14.02.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1002/jsfa.11496

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM32953095X